These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16246032)

  • 1. Control of the CFTR channel's gates.
    Vergani P; Basso C; Mense M; Nairn AC; Gadsby DC
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1003-7. PubMed ID: 16246032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains.
    Vergani P; Lockless SW; Nairn AC; Gadsby DC
    Nature; 2005 Feb; 433(7028):876-80. PubMed ID: 15729345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
    Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
    J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel.
    Tsai MF; Li M; Hwang TC
    J Gen Physiol; 2010 May; 135(5):399-414. PubMed ID: 20421370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.
    Csanády L; Chan KW; Nairn AC; Gadsby DC
    J Gen Physiol; 2005 Jan; 125(1):43-55. PubMed ID: 15596536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle.
    Csanády L; Nairn AC; Gadsby DC
    J Gen Physiol; 2006 Nov; 128(5):523-33. PubMed ID: 17043148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.
    Zeltwanger S; Wang F; Wang GT; Gillis KD; Hwang TC
    J Gen Physiol; 1999 Apr; 113(4):541-54. PubMed ID: 10102935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
    Basso C; Vergani P; Nairn AC; Gadsby DC
    J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant cycles at CFTR's non-canonical ATP-binding site support little interface separation during gating.
    Szollosi A; Muallem DR; Csanády L; Vergani P
    J Gen Physiol; 2011 Jun; 137(6):549-62. PubMed ID: 21576373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gating of the CFTR Cl- channel by ATP-driven nucleotide-binding domain dimerisation.
    Hwang TC; Sheppard DN
    J Physiol; 2009 May; 587(Pt 10):2151-61. PubMed ID: 19332488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis transmembrane conductance regulator: a chloride channel gated by ATP binding and hydrolysis.
    Bompadre SG; Hwang TC
    Sheng Li Xue Bao; 2007 Aug; 59(4):431-42. PubMed ID: 17700963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of MgATP-dependent gating of CFTR Cl- channels.
    Vergani P; Nairn AC; Gadsby DC
    J Gen Physiol; 2003 Jan; 121(1):17-36. PubMed ID: 12508051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator.
    Muallem D; Vergani P
    Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):247-55. PubMed ID: 18957373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
    Yu YC; Sohma Y; Hwang TC
    J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional similarities between the nucleotide-binding domains of CFTR and GTP-binding proteins.
    Carson MR; Welsh MJ
    Biophys J; 1995 Dec; 69(6):2443-8. PubMed ID: 8599650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Changes of CFTR upon Phosphorylation and ATP Binding.
    Zhang Z; Liu F; Chen J
    Cell; 2017 Jul; 170(3):483-491.e8. PubMed ID: 28735752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine accessibility probes timing and extent of NBD separation along the dimer interface in gating CFTR channels.
    Chaves LA; Gadsby DC
    J Gen Physiol; 2015 Apr; 145(4):261-83. PubMed ID: 25825169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.
    Wei S; Roessler BC; Chauvet S; Guo J; Hartman JL; Kirk KL
    J Biol Chem; 2014 Jul; 289(29):19942-57. PubMed ID: 24876383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator, an ABC transporter, catalyze adenylate kinase activity but not ATP hydrolysis.
    Gross CH; Abdul-Manan N; Fulghum J; Lippke J; Liu X; Prabhakar P; Brennan D; Willis MS; Faerman C; Connelly P; Raybuck S; Moore J
    J Biol Chem; 2006 Feb; 281(7):4058-68. PubMed ID: 16361259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
    Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
    Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.